Skip to main content
. Author manuscript; available in PMC: 2014 Feb 27.
Published in final edited form as: Drug Discov Today. 2010 Jun 8;15(0):596–609. doi: 10.1016/j.drudis.2010.06.001

FIGURE 1.

FIGURE 1

(a) Structure of the de-esterified form of the neuraminidase inhibitor oseltamivir in complex with the H274Y mutant of influenza virus N1 neuraminidase that displays resistance to treatment with oseltamivir (PDBID 3CL0 [134]). (b) Schematic representations of the natural substrate (neuraminic acid). (c) Schematic representations of the inhibitor.